UBS Group’s Wright Medical Group, Inc. Contingent Value Right WMGIZ Stock Holding History

UBS Group’s Portfolio WMGIZ Stock Details WMGIZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-25,662	Closed	–	–	8531
2018 Q4	$0	Buy	25,662 +18,605	+264%	+$19.7K	﹤0.01%	8557
2018 Q3	$10K	Buy	7,057 +1,600	+29%	+$2.17K	﹤0.01%	7194
2018 Q2	$7K	Buy	5,457 +200	+4%	+$261	﹤0.01%	7376
2018 Q1	$7K	Buy	5,257 +1,500	+40%	+$2.15K	﹤0.01%	7117
2017 Q4	$6K	Buy	3,757 +3,657	+3,657%	+$5.65K	﹤0.01%	7343
2017 Q3	$0	Hold	100	–	–	﹤0.01%	8202
2017 Q2	$0	Hold	100	–	–	﹤0.01%	8223
2017 Q1	$0	Hold	100	–	–	﹤0.01%	8220
2016 Q4	$0	Hold	100	–	–	﹤0.01%	8235
2016 Q3	$0	Hold	100	–	–	﹤0.01%	8127
2016 Q2	$0	Hold	100	–	–	﹤0.01%	8136
2016 Q1	$0	Hold	100	–	–	﹤0.01%	8499
2015 Q4	$0	Buy	+100	New	+$102	﹤0.01%	8722

Other funds holding WMGIZ

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

UBS Group's WMGIZ Position: Q1 2019 in Review

UBS Group sold out of Wright Medical Group, Inc. Contingent Value Right (WMGIZ) in Q1 2019, closing a stake of 25,662 shares.

UBS Group first reported a position in WMGIZ in Q4 2015 and held it in 13 quarters. The position peaked at $10K in Q3 2018. 2 funds tracked by Wall St. Rank hold WMGIZ as of Q1 2019.

UBS Group reported no remaining Wright Medical Group, Inc. Contingent Value Right position as of Q1 2019 after selling out during the quarter.
UBS Group sold 25,662 Wright Medical Group, Inc. Contingent Value Right shares in Q1 2019.
UBS Group first reported a position in Wright Medical Group, Inc. Contingent Value Right in Q4 2015 and held it in 13 quarters.
UBS Group's Wright Medical Group, Inc. Contingent Value Right position peaked at $10K in Q3 2018.
2 funds tracked by Wall St. Rank held Wright Medical Group, Inc. Contingent Value Right as of Q1 2019.

Based on UBS Group's 13F filing for Q1 2019, filed 14 May 2019.